Literature DB >> 10426839

Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure.

D Bonaduce1, M Petretta, F Marciano, M L Vicario, C Apicella, M A Rao, E Nicolai, M Volpe.   

Abstract

BACKGROUND: Decreased heart rate variability (HRV), indicating derangement in cardiac autonomic control, has been reported in patients with chronic heart failure. However, the independent and incremental prognostic value of HRV over clinical data and measures of left ventricular dysfunction has been less thoroughly investigated. This study was designed to evaluate the predictive value of HRV and Poincaré plots as assessed by 24-hour Holter recording in patients with chronic heart failure.
METHODS: Ninety-seven patients, mean age 55 +/- 13 years, with radionuclide left ventricular ejection fraction </=40% underwent echocardiographic examination and 24-hour Holter recording. Heart failure was caused by coronary artery disease in 57 patients (59%) and idiopathic dilated cardiomyopathy in 40 (41%).
RESULTS: During follow-up (39 +/- 18 months), 32 cardiac deaths occurred. By Cox multivariate analysis, significant predictors of death were left ventricular end-systolic volume (hazard ratio 1.04), low- to high-frequency ratio (hazard ratio 0.09), percentage of differences between successive normal R-R intervals >50 ms (hazard ratio 0.93), and age (hazard ratio 1.06). Furthermore, HRV analysis improved (P <. 001) the prognostic power of a model including clinical and echocardiographic data, left ventricular ejection fraction, and ventricular arrhythmias at Holter recording, whereas the inclusion of Poincaré plots did not add further predictive value.
CONCLUSIONS: Our investigation demonstrated that HRV has independent and incremental prognostic value in patients with chronic heart failure and seems useful to stratify patients at high risk of cardiac death.

Entities:  

Mesh:

Year:  1999        PMID: 10426839     DOI: 10.1016/s0002-8703(99)70112-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  13 in total

1.  Electrocardiographic findings in sickle cell cardiovascular autonomic neuropathy.

Authors:  N I Oguanobi; E C Ejim; B C Anisiuba; B J C Onwubere; S O Ike; O G Ibegbulam
Journal:  Clin Auton Res       Date:  2012-01-20       Impact factor: 4.435

2.  Enhancing the deceleration capacity index of heart rate by modified-phase-rectified signal averaging.

Authors:  Qing Pan; Yuexian Gong; Shijin Gong; Qijun Hu; Zhaocai Zhang; Jing Yan; Gangmin Ning
Journal:  Med Biol Eng Comput       Date:  2010-03-06       Impact factor: 2.602

3.  Relation of anemia to low heart rate variability in patients with coronary heart disease (from the Heart and Soul study).

Authors:  Anil Gehi; Joachim Ix; Michael Shlipak; Sharon S Pipkin; Mary A Whooley
Journal:  Am J Cardiol       Date:  2005-06-15       Impact factor: 2.778

4.  Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects.

Authors:  A C Nóbrega; A F dos Reis; R S Moraes; B G Bastos; E L Ferlin; J P Ribeiro
Journal:  Clin Auton Res       Date:  2001-02       Impact factor: 4.435

Review 5.  Clinical review: a review and analysis of heart rate variability and the diagnosis and prognosis of infection.

Authors:  Saif Ahmad; Anjali Tejuja; Kimberley D Newman; Ryan Zarychanski; Andrew Je Seely
Journal:  Crit Care       Date:  2009-11-24       Impact factor: 9.097

Review 6.  AKAP-scaffolding proteins and regulation of cardiac physiology.

Authors:  J R H Mauban; M O'Donnell; S Warrier; S Manni; M Bond
Journal:  Physiology (Bethesda)       Date:  2009-04

Review 7.  Should a statin be prescribed to every patient with heart failure?

Authors:  Sofia G Tsouli; Evangelos N Liberopoulos; John A Goudevenos; Dimitri P Mikhailidis; Moses S Elisaf
Journal:  Heart Fail Rev       Date:  2007-08-12       Impact factor: 4.214

8.  Development of more erratic heart rate patterns is associated with mortality post-myocardial infarction.

Authors:  Phyllis K Stein; QuyChi Le; Peter P Domitrovich
Journal:  J Electrocardiol       Date:  2008 Mar-Apr       Impact factor: 1.438

9.  Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease.

Authors:  Roddy McDowell; Jennifer S Li; Daniel Kelly Benjamin; Claire Morgan; Alison Becker; Priya S Kishnani; Ronald J Kanter
Journal:  Genet Med       Date:  2008-10       Impact factor: 8.822

Review 10.  Therapeutic and diagnostic role of electrical devices in acute heart failure.

Authors:  Frieder Braunschweig
Journal:  Heart Fail Rev       Date:  2007-06       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.